| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 5 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.97M | $1.17M | - | |
| Dir | 521.7K | $310.4K | - | |
| COO | 401.8K | $239.0K | - | |
| CEO | 63.9K | $38.0K | - | |
| Dir | 28.4K | $16.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2016 | Equels Thomas K. | CEO, President | Buy | 48,000 | $0.12 | $5,683.20 | +2.9% | |
| Jul 1, 2016 | Equels Thomas K. | CEO,President | Buy | 171,000 | $0.12 | $20,424.30 | +1.8% | |
| Mar 18, 2016 | Equels Thomas K. | CEO,Pres,Exec Vice Chairman | Buy | 30,000 | $0.13 | $3,966.00 | +2.1% | |
| Mar 11, 2016 | Equels Thomas K. | CEO,Pres,Exec Vice Chairman | Buy | 40,000 | $0.16 | $6,310.00 | New | |
| Mar 10, 2016 | Equels Thomas K. | CEO,Pres,Exec Vice Chairman | Buy | 30,000 | $0.16 | $4,890.00 | New | |
| Aug 20, 2015 | Carter William A | CEO | Buy | 25,000 | $0.18 | $4,487.50 | +2.1% | |
| Aug 18, 2015 | Carter William A | CEO | Buy | 25,000 | $0.18 | $4,550.00 | +2.1% | |
| Aug 17, 2015 | Carter William A | CEO | Buy | 25,000 | $0.18 | $4,537.50 | +2.2% | |
| Aug 14, 2015 | Equels Thomas K. | CFO, Pres.,Sec., Vice Chairman | Buy | 79,104 | $0.18 | $14,240.42 | +2.0% | |
| Apr 28, 2015 | Carter William A | CEO | Buy | 100,000 | $0.24 | $24,200.00 | +9.5% |